These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 19721235

  • 1. Neonatal phencyclidine treatment in mice induces behavioral, histological and neurochemical abnormalities in adulthood.
    Nakatani-Pawlak A, Yamaguchi K, Tatsumi Y, Mizoguchi H, Yoneda Y.
    Biol Pharm Bull; 2009 Sep; 32(9):1576-83. PubMed ID: 19721235
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neonatal phencyclidine and social isolation in the rat: effects of clozapine on locomotor activity, social recognition, prepulse inhibition, and executive functions deficits.
    Hamieh AM, Babin D, Sablé E, Hernier AM, Castagné V.
    Psychopharmacology (Berl); 2021 Feb; 238(2):517-528. PubMed ID: 33169202
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels.
    Metaxas A, Willems R, Kooijman EJ, Renjaän VA, Klein PJ, Windhorst AD, Donck LV, Leysen JE, Berckel BN.
    J Neurosci Res; 2014 Nov; 92(11):1599-607. PubMed ID: 24953757
    [Abstract] [Full Text] [Related]

  • 6. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments.
    Castañé A, Santana N, Artigas F.
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4085-97. PubMed ID: 25943167
    [Abstract] [Full Text] [Related]

  • 7. Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration.
    Elsworth JD, Groman SM, Jentsch JD, Valles R, Shahid M, Wong E, Marston H, Roth RH.
    Neuropharmacology; 2012 Mar; 62(3):1442-52. PubMed ID: 21875607
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study.
    Steinpreis RE, Salamone JD.
    Brain Res; 1993 May 28; 612(1-2):263-70. PubMed ID: 8330204
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A, Advani T, Cassano T, Hensler JG, Giuffrida A.
    Int J Neuropsychopharmacol; 2010 Apr 28; 13(3):373-86. PubMed ID: 19607756
    [Abstract] [Full Text] [Related]

  • 13. Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.
    Guidali C, Viganò D, Petrosino S, Zamberletti E, Realini N, Binelli G, Rubino T, Di Marzo V, Parolaro D.
    Int J Neuropsychopharmacol; 2011 Feb 28; 14(1):17-28. PubMed ID: 20196921
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of parvalbumin in neonatal phencyclidine-treated rats and socially isolated rats.
    Kaalund SS, Riise J, Broberg BV, Fabricius K, Karlsen AS, Secher T, Plath N, Pakkenberg B.
    J Neurochem; 2013 Feb 28; 124(4):548-57. PubMed ID: 23083323
    [Abstract] [Full Text] [Related]

  • 15. Postnatal phencyclidine administration selectively reduces adult cortical parvalbumin-containing interneurons.
    Wang CZ, Yang SF, Xia Y, Johnson KM.
    Neuropsychopharmacology; 2008 Sep 28; 33(10):2442-55. PubMed ID: 18059437
    [Abstract] [Full Text] [Related]

  • 16. Repeated low dose of phencyclidine administration impairs spatial learning in mice: blockade by clozapine but not by haloperidol.
    Beraki S, Kuzmin A, Tai F, Ogren SO.
    Eur Neuropsychopharmacol; 2008 Jul 28; 18(7):486-97. PubMed ID: 18242064
    [Abstract] [Full Text] [Related]

  • 17. Myelination deficit in a phencyclidine-induced neurodevelopmental model of schizophrenia.
    Zhang R, He J, Zhu S, Zhang H, Wang H, Adilijiang A, Kong L, Wang J, Kong J, Tan Q, Li XM.
    Brain Res; 2012 Aug 21; 1469():136-43. PubMed ID: 22750584
    [Abstract] [Full Text] [Related]

  • 18. Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review.
    Grayson B, Barnes SA, Markou A, Piercy C, Podda G, Neill JC.
    Curr Top Behav Neurosci; 2016 Aug 21; 29():403-428. PubMed ID: 26510740
    [Abstract] [Full Text] [Related]

  • 19. ErbB signaling antagonist ameliorates behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers.
    Tadmor H, Golani I, Doron R, Kremer I, Shamir A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar 02; 82():322-331. PubMed ID: 28818421
    [Abstract] [Full Text] [Related]

  • 20. Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice.
    Rodríguez G, Neugebauer NM, Yao KL, Meltzer HY, Csernansky JG, Dong H.
    Pharmacol Biochem Behav; 2017 Aug 02; 159():6-11. PubMed ID: 28648819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.